Spero Therapeutics (SPRO) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.34
-0.04
0.25
0.55

Details

Expected EPS
-0.34
Actual EPS
-0.23
Surprise EPS
0.11
Surprise Percent
+32.35%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.23 per share for Q2 2023.

0 Comments

Share your thoughts